Generation of human iPS cell line SKiPSc1 from healthy Human Neonatal Foreskin Fibroblast cells

Abdullah Alawad1, Othman Alhazzaa1, Saleh Altuwaijri2

  • 1National Center for Stem Cell Technology (NCSCT), Life Sciences and Environment Research Institute (LSERI), King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.

Stem Cell Research
|August 26, 2016
PubMed

Insights

A new induced pluripotent stem (iPS) cell line, SKiPSc1, was created from human neonatal foreskin fibroblasts. This cell line was reprogrammed using non-integrating Sendai viral vectors for potential research applications.

Area of Science:

  • Stem Cell Biology
  • Cellular Reprogramming
  • Biotechnology

Background:

  • Induced pluripotent stem cells (iPSCs) are crucial for regenerative medicine and disease modeling.
  • Generating patient-specific iPSCs requires efficient and safe reprogramming methods.
  • Human Neonatal Foreskin Fibroblasts (HNFFs) are a common source for somatic cells used in reprogramming.

Purpose of the Study:

  • To establish a novel induced pluripotent stem (iPS) cell line, designated SKiPSc1.
  • To characterize the reprogramming efficiency and pluripotency of the generated iPS cell line.
  • To provide a valuable tool for stem cell research and therapeutic development.

Main Methods:

  • Human Neonatal Foreskin Fibroblasts (HNFFs) from a healthy donor were utilized.
  • Non-integrating Sendai viral vectors were employed for reprogramming.
  • Viral vectors expressed key pluripotency factors: Oct3/4, Sox2, c-Myc, and Klf4.

Main Results:

  • The SKiPSc1 iPS cell line was successfully generated from HNFFs.
  • Reprogramming was achieved using non-integrating Sendai viral vectors, minimizing genomic integration risks.
  • The resulting iPS cells express established pluripotency markers (data not shown in abstract).

Conclusions:

  • The SKiPSc1 iPS cell line represents a new resource for stem cell research.
  • The use of non-integrating Sendai vectors offers a safer alternative for iPS cell generation.
  • This iPS cell line holds promise for future studies in developmental biology and regenerative medicine.